Considering the interdisciplinary nature of both Basic and Translational Research projects, collaborative studies among geneticists, molecular biologists, neuroscientists, child neurologists, medicinal chemists and pharmacologists engaged in drug discovery and other clinical or basic researchers are encouraged. Teams working together from different institutions as well as within pharmaceutical and biotechnology industries are strongly encouraged.
Grants are made for technical support, supplies, equipment and relevant travel. For HeART and Regular Research Grant mechanisms, PI salary support will now be considered on a case-by-case basis and may be limited to 20% of the total award. Indirect costs of up to 10% of direct costs may be included with the request amount. Proposals for less than the maximum amount are encouraged. Second year funding for all awards is non-competitive but is based on review of the first year’s progress report.
International Rett Syndrome Foundation accepts qualified, scientific proposals from academic institutions, existing, private, early-stage pharmaceutical and biotechnology industries (if a clear need for non-profit funding to support the project is demonstrated and justified) and other non-profit organizations worldwide. Investigators with “Research Associate” as their title are eligible to apply for mentored training fellowships only. Exceptions may be considered on a case by case basis.
The Two-Step Grant Application Process
The investigator must submit a Letter of Intent (LOI) describing the project in a succinct manner. The LOI should include objectives and specific aims of the proposal, research design and methods, qualifications of the Principal Investigator, mentor (if applicable) and other principal investigators involved in the project. Preliminary data must be included within the page limitations. LOIs for the Translational and Neuro-Habilitation HeART, Basic Research Grants, Mentored Training Fellowships and Pilot Grants should not exceed two pages. LOIs for the Translational and Clinical ANGEL grant mechanism should not exceed three pages.
After review of the LOI, we will contact the investigator via email to invite or decline a full proposal. Successful applicants will be provided with specific instructions to complete and submit the application form.
Your application will be peer-reviewed and scored using the NIH’s 9 point rating scale. The application will also undergo a programmatic review by IRSF and its internal Research Advisory Committee who advise the IRSF Board on funding decisions.